Profile

HQ: Austin, TX, USA
Founded: 2007
Symbol: HPST (OTC)

Focus: Neutral

RVDO was a non-operating oil and gas company that outsourced most of it work. Their projects included natural gas exploration, development, and production, mainly in south Texas and the Gulf Coast. They also held gas leases.

On August 6th, 2020 they announced an asset purchase agreement with Hempstract, LLC to take control of 3 kg of CBD isolate and all equipment held at Hempstract’s Washington location. The sale price was $36.8 million in an all-stock deal.

Size: Weak

Market Cap: $6.31 mil
Enterprise Value: $6.1 mil
Number of Employees: 3

Operations: Neutral

Cultivation: None
Current production: Hempstract produces THC-free CBD isolate and distillate oils along with whole hemp plant extracts to be used downstream in topicals and pet products.

Distribution: None
Direct sales: Yes

Store networks: Signed a recent tolling (concentrate manufacturing) agreement with IsoPhlora, Inc. a Portland, Oregon-based company.

Hempstract with retain 40% of finished products from tolling agreement. This type of arrangement is typical for tolling operators.

Integration/Diversification:
Vertically integrated: No
Horizontally diversified: No

Financials: Weak

Revenue (2020): RVDO reported no revenue in Q1 and Q2 2020
Shares Outstanding (diluted): 26.7 million
Return on Equity: -56.6%

Should I buy Hempstract Labs Hemp Stock?

Follow Stephen Goldman as he evaluates Hempstract Labs (HPST) using the MACD, CCI, and Bollinger bands to learn about trading opportunities with RVDO during the fundamental “pop.”

Remember sound cannabis stock trading strategies include both Fundamental Analysis and Technical Analysis.

Bottom Line: Is HPST Hemp Stock a Buy?

Recommendation: Weak

Riverdale Oil & Gas Corp was an exploratory oil and natural gas company active in South Texas and the Gulf Coast. They were struggling. They had 5 leased wells and all were either lost or reported very low production. In fact, they had reported losses of around $700k every year for the last 11 years. Not great.

Obviously, they needed a pivot and the hemp industry provided just that. In February they started due diligence on Hempstract LLC, a Warden, Washington business that produced CBD distillate oil and THC-free CBD isolate for use in topical and infused products. In August they closed on that deal which included assets of 3.1 kg of CBD isolate and manufacturing equipment work $750k. Hempstract was renovating an old missile facility to scale up production.

This brought a lot of excitement to the investing world. It was not warranted. There are 100s of companies in the United States doing what Hempstract was doing. Most are privately held but some are not. Hempstract does have some tolling agreements but that is about it. Given the market saturation and ongoing constriction that is happening in the CBD industry, it does not look promising. The HPST stock did pop all the way to nearly $2.00 but it is now back down to where it started at $0.24. Look for it to drop even more.

The company has zero revenue. Their Annual Report Form 10-K filed with the SEC actually says “At this time, we have not identified specific planned revenue streams. During the years ended April 30, 2020, and 2019, we did not recognize any revenue.” The company hasn’t made a dollar in over 2 years. They’ve signed only non-binding letters of intent and have followed through with no transactions. All this “activity” is good for press releases which may drive stock prices up. Once the stock price goes up nothing much else happens. The company has yet to act on any of these letters of intent. Most are just press releases.

For all the reasons above, we rate this stock as Weak but check out our other featured companies for many other winners in the cannabis and hemp industry.